Scenarios that move VTGN
Vistagen Therapeutics, Inc. - Common Stock
Scenarios that move VTGN: 1 analysis, 1 positive, 0 negative.
- · Definium reports second Phase III success in anxiety program — ▲ · impact +65 · confidence low · horizon weeks
Vistagen Therapeutics, Inc. - Common Stock
Scenarios that move VTGN: 1 analysis, 1 positive, 0 negative.